tiprankstipranks
Trending News
More News >
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
US Market

Eupraxia Pharmaceuticals (EPRX) Cash flow

Compare
6 Followers

Eupraxia Pharmaceuticals Cash Flow

EPRX's free cash flow for Q1 2025 was C$-6.17M. For the 2025 fiscal year, EPRX's free cash flow was decreased by C$-2.08M and operating cash flow was C$-6.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
C$ -29.99MC$ -27.92MC$ -18.78MC$ -14.64MC$ -403.93K
Investing Cash Flow
C$ -75.16KC$ -99.03KC$ 8.70MC$ -14.45MC$ 24.62K
Financing Cash Flow
C$ 45.78MC$ 27.84MC$ 13.52MC$ 49.92MC$ -626.64K
End Cash Position
C$ 33.10MC$ 19.34MC$ 24.74MC$ 20.89MC$ 150.13K
Free Cash Flow
C$ -30.10MC$ -28.02MC$ -19.08MC$ -15.07MC$ -403.93K
Currency in CAD

Eupraxia Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis